Reproductive Biology Associates: Coronavirus (COVID-19) Update
Posted on March 16, 2020
Patient Update – December 2020
Feel free to review the statements below for more information about the COVID-19 vaccine. These resources are not medical advice:
Click here to read the ASRM statement issued on December 16, 2020
Click here to read the joint statement from the ASRM and other OBGYN groups issued on December 16, 2020
Click here to read official guidelines from the American College of OBGYN on COVID vaccines and pregnancy issued on December 13, 2020
Reproductive Biology Associates is actively monitoring all developments related to COVID-19.
As always, our top priority is the health and safety of our patients and staff. We are utilizing all guidance available from ASRM, the CDC and the Georgia Department of Health to institute safety precautions.
If you or anyone in your household is currently exhibiting flu-like symptoms (cold, fever, cough, and/or shortness of breath), please seek treatment from your primary care provider. Additionally, please call our office at 404-257-1900 before coming to our facility to determine how best to proceed.
We are here. We are open. Welcome back.
We continue to maintain a safe and controlled start of treatment cycles. All Satellite locations are now open for scheduled appointments.
In accordance with social distancing, we are implementing a gradual re-start of treatment cycles to regulate the number of individuals onsite each day. We are continuing to limit the number of patients that may start a treatment cycle on any specific date.
Many patients who experienced a cycle disruption due to COVID-19 have already spoken with our Patient Care Coordination team to discuss cycle start timing. If you have not yet spoken to your Coordinator, and if you wish to initiate your treatment within the next two (2) months, please contact your RBA care team. Our team will review your protocol, medications, pre-cycle checklist, insurance, and authorization. You will also speak with a nurse to assess your current health and identify any final updates required for your pre-cycle checklist.
Onsite Safety Protocols
Please be advised of the following updates to RBA’s operations:
Appointments are required for morning monitoring.
This is an important change to our prior “walk-in” policy. In order to reduce the number of individuals in our waiting areas, each patient will receive an appointment for morning monitoring. To protect the safety of our patients and staff, patients will only be allowed to enter the Center during their scheduled appointment.
Patients are required to wear masks while onsite.
In compliance with CDC recommendations, all individuals at Reproductive Biology Associates will be required to wear face masks while onsite.
All patients will need to wear a face mask or facial protection that covers both mouth and nose in order to enter the facility. RBA will not provide a face mask – each patient is responsible for obtaining his or her own face mask. If a patient cannot secure a medical-grade face mask, the following are acceptable face protection options: any bandana, scarf, or handmade mask that fully covers the mouth and nose.
RBA will continue our guest limitation policy.
In observance of social distancing and to minimize the number of individuals onsite, only the scheduled patient will be admitted to the facility. All patients visiting the Center for morning monitoring, bloodwork, or imaging scans must attend without any visitors present. Children are not permitted onsite. We apologize for any inconvenience, however we are committed to protecting the safety of our patients and staff by limiting the number of individuals in our space.
All patients will be screened for temperature and health at entry.
To protect our patients, our staff, and our current (and future!) families, every individual entering our Center will be required to pass a temperature screening and will be screened for COVID-19 related symptoms. We regret the necessity of this intrusion upon your time.
Cycle Disruption Policy
If an individual demonstrates symptoms of illness during a treatment cycle, or if the individual is mid-cycle and tests positive for COVID-19, the cycle will be cancelled or suspended.
If this cancellation or suspension occurs prior to retrieval, we will issue a credit balance in accordance with services rendered during the cycle. Credit balances will be established on a case-by-case basis. We are not able to extend credit toward products or services provided by third parties (products or services provided by third parties include but are not limited to medications, phlebotomy, anesthesia, genetic testing, tissue storage fees, etc).
New Patient Consults
RBA is utilizing telehealth solutions to fully enable all New Patient Consults.
If you would like to schedule a New Patient Consult with one of our fertility specialists, please click here to request an appointment.
If you are currently scheduled for a New Patient Consult with one of our fertility specialists, a member of your care team will contact you to determine if a telehealth session for your scheduled appointment is appropriate.
If you have questions about your care at Reproductive Biology Associates, please contact our office at 404-257-1900.
If your request is urgent and after hours please call our answering service at 1-800-863-2938.
We look forward to supporting your journey toward parenthood.
Page Updated: Friday July 31st, 2020 for launch on Monday, August 3rd, 2020